RARA CRAFT DATABASE for FDA Medical Devices
510(k)K260755

FDA DEVICE FACTS

OptraSCAN System

Optrascan, Inc.

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEJuly 2, 2026PRODUCT CODENOTCLINICAL AREAClinical Laboratory

Indications for use

The OptraSCAN System is an automated digital slide creation, management, viewing and analysis system which consists of the OS-Ultra Scanner, Color Display Monitor (Model No. Dell U2424HE) and a Workstation, preinstalled with software to operate the scanner and the ImagePath application (Image Management software and HER2 Image Analysis Software).

The OptraSCAN System is intended for in vitro diagnostic use as an aid to the pathologist in the review and semi-quantitative scoring of HER2 protein expression in scanned digital images obtained using OS-Ultra Scanner of slides prepared from formalin-fixed paraffin embedded (FFPE) breast tissue and stained with the Dako HercepTestTM.

The HER2 Image Analysis Software outputs the scores for individual Regions of Interest (ROIs) as well as the slide level score based on all the ROIs. The pathologist is responsible for making the final decision of the score, based on the output provided by the system. The OptraSCAN System software makes no independent interpretations of the data. Note: The HER2 Image Analysis Software is an adjunctive computer-assisted methodology to assist qualified pathologists in HER2 scoring in breast cancer. The accuracy of the test result depends upon the quality of the immunohistochemical staining.

It is the responsibility of a qualified pathologist to employ appropriate morphological studies and controls as specified in the instructions for use for the Dako HercepTest TM to assure the validity of the HER2 Image Analysis Software assisted HER2 score. The actual correlation of the Dako HercepTestTM to Herceptin® clinical outcome has not been established.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026